Explanation and interpretation of blood transfusion provisions for children undergoing cardiac surgery in the national health standard "Guideline for pediatric transfusion"

Rong HUANG, Qing-Nan HE, Ming-Yan HEI, Ming-Hua YANG, Xiao-Fan ZHU, Jun LU, Xiao-Jun XU, Tian-Ming YUAN, Rong ZHANG, Xu WANG, Jing WANG, Zhi-Li SHAO, Ming-Yi ZHAO, Yong-Jian GUO, Xin-Yin WU, Jia-Rui CHEN, Qi-Rong CHEN, Jia GUO, Rong GUI, Jin-Ping LIU

Chinese Journal of Contemporary Pediatrics ›› 2025, Vol. 27 ›› Issue (7) : 778-785.

PDF(600 KB)
HTML
PDF(600 KB)
HTML
Chinese Journal of Contemporary Pediatrics ›› 2025, Vol. 27 ›› Issue (7) : 778-785. DOI: 10.7499/j.issn.1008-8830.2503114
GUIDELINE INTERPRETATION: GUIDELINE FOR PEDIATRIC TRANSFUSION

Explanation and interpretation of blood transfusion provisions for children undergoing cardiac surgery in the national health standard "Guideline for pediatric transfusion"

Author information +
History +

Abstract

To guide clinical blood transfusion practices in pediatric patients, the National Health Commission has issued the health standard "Guideline for pediatric transfusion" (WS/T 795-2022). Children undergoing cardiac surgery are at high risk of bleeding, and the causes of perioperative anemia and coagulation disorders in neonates and children are complex and varied, often necessitating the transfusion of allogeneic blood components. This guideline provides direction and recommendations for specific measures in blood management for children undergoing cardiac surgery before, during, and after surgery. This article interprets the background and evidence for the formulation of the blood transfusion provisions for children undergoing cardiac surgery, hoping to facilitate the understanding and implementation of this guideline.

Key words

Cardiac surgery / Blood management / Cardiopulmonary bypass / Restrictive transfusion strategy / Child

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
Rong HUANG , Qing-Nan HE , Ming-Yan HEI , et al . Explanation and interpretation of blood transfusion provisions for children undergoing cardiac surgery in the national health standard "Guideline for pediatric transfusion"[J]. Chinese Journal of Contemporary Pediatrics. 2025, 27(7): 778-785 https://doi.org/10.7499/j.issn.1008-8830.2503114

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis
[1]
Despotis GJ, Gravlee G, Filos K, et al. Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques[J]. Anesthesiology, 1999, 91(4): 1122-1151. DOI: 10.1097/00000542-199910000-00031 .
https://www.ncbi.nlm.nih.gov/pubmed/10519514
Cited in this article [1]
[2]
Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review[J]. Intensive Care Med, 2004, 30(10): 1873-1881. DOI: 10.1007/s00134-004-2388-0 .
https://www.ncbi.nlm.nih.gov/pubmed/15278267
Cited in this article [1]
[3]
中华人民共和国国家卫生健康委员会法规司. 关于发布《输血相容性检测标准》等3项推荐性卫生行业标准的通告: 国卫通〔2022〕1号[EB/OL]. (2022-02-23)[2022-09-01].
https://www.nhc.gov.cn/fzs/c100048/202202/fc6310d72212427c9f5ef2f7f0166aac.shtml
Cited in this article [1]
[4]
Faraoni D, Meier J, New HV, et al. Patient blood management for neonates and children undergoing cardiac surgery: 2019 NATA guidelines[J]. J Cardiothorac Vasc Anesth, 2019, 33(12): 3249-3263. DOI: 10.1053/j.jvca.2019.03.036 .
https://www.ncbi.nlm.nih.gov/pubmed/31076306
Cited in this article [4]
[5]
Goobie SM, Faraoni D, Zurakowski D, et al. Association of preoperative anemia with postoperative mortality in neonates[J]. JAMA Pediatr, 2016, 170(9): 855-862. DOI: 10.1001/jamapediatrics.2016.1032 .
https://www.ncbi.nlm.nih.gov/pubmed/27428875
Cited in this article [1]
[6]
Faraoni D, DiNardo JA, Goobie SM. Relationship between preoperative anemia and in-hospital mortality in children undergoing noncardiac surgery[J]. Anesth Analg, 2016, 123(6): 1582-1587. DOI: 10.1213/ANE.0000000000001499 .
https://www.ncbi.nlm.nih.gov/pubmed/27870741
Cited in this article [1]
[7]
Mulaj M, Faraoni D, Willems A, et al. Predictive factors for red blood cell transfusion in children undergoing noncomplex cardiac surgery[J]. Ann Thorac Surg, 2014, 98(2): 662-667. DOI: 10.1016/j.athoracsur.2014.04.089 .
https://www.ncbi.nlm.nih.gov/pubmed/24968768
Cited in this article [1]
[8]
Park SK, Hur M, Kim E, et al. Risk factors for acute kidney injury after congenital cardiac surgery in infants and children: a retrospective observational study[J]. PLoS One, 2016, 11(11): e0166328. PMCID: PMC5104485. DOI: 10.1371/journal.pone.0166328 .
https://www.ncbi.nlm.nih.gov/pubmed/27832187
Cited in this article [1]
[9]
Williams GD, Bratton SL, Ramamoorthy C. Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery[J]. Anesth Analg, 1999, 89(1): 57-64. DOI: 10.1097/00000539-199907000-00011 .
https://www.ncbi.nlm.nih.gov/pubmed/10389779
Cited in this article [1]
[10]
Moganasundram S, Hunt BJ, Sykes K, et al. The relationship among thromboelastography, hemostatic variables, and bleeding after cardiopulmonary bypass surgery in children[J]. Anesth Analg, 2010, 110(4): 995-1002. DOI: 10.1213/ANE.0b013e3181cd6d20 .
https://www.ncbi.nlm.nih.gov/pubmed/20142345
Cited in this article [1]
[11]
Hayashi T, Sakurai Y, Fukuda K, et al. Correlations between global clotting function tests, duration of operation, and postoperative chest tube drainage in pediatric cardiac surgery[J]. Paediatr Anaesth, 2011, 21(8): 865-871. DOI: 10.1111/j.1460-9592.2011.03524.x .
https://www.ncbi.nlm.nih.gov/pubmed/21251146
Cited in this article [1]
[12]
New HV, Berryman J, Bolton-Maggs PH, et al. Guidelines on transfusion for fetuses, neonates and older children[J]. Br J Haematol, 2016, 175(5): 784-828. DOI: 10.1111/bjh.14233 .
https://www.ncbi.nlm.nih.gov/pubmed/27861734
Cited in this article [2]
[13]
Sniecinski RM, Chandler WL. Activation of the hemostatic system during cardiopulmonary bypass[J]. Anesth Analg, 2011, 113(6): 1319-1333. DOI: 10.1213/ANE.0b013e3182354b7e .
https://www.ncbi.nlm.nih.gov/pubmed/22003219
Cited in this article [1]
[14]
Despotis GJ, Avidan MS, Hogue CW. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation[J]. Ann Thorac Surg, 2001, 72(5): S1821-S1831. DOI: 10.1016/s0003-4975(01)03211-8 .
https://www.ncbi.nlm.nih.gov/pubmed/11722116
Cited in this article [1]
[15]
中国心胸血管麻醉学会血液管理分会. 心血管手术患者血液管理专家共识[J]. 中国输血杂志, 2018, 31(4): 321-325. DOI: 10.13303/j.cjbt.issn.1004-549x.2018.04.001 .
Cited in this article [1]
[16]
Faraoni D, Willems A, Melot C, et al. Efficacy of tranexamic acid in paediatric cardiac surgery: a systematic review and meta-analysis[J]. Eur J Cardiothorac Surg, 2012, 42(5): 781-786. DOI: 10.1093/ejcts/ezs127 .
https://www.ncbi.nlm.nih.gov/pubmed/22531271
Cited in this article [1]
[17]
Eaton MP. Antifibrinolytic therapy in surgery for congenital heart disease[J]. Anesth Analg, 2008, 106(4): 1087-1100. DOI: 10.1213/ane.0b013e3181679555 .
https://www.ncbi.nlm.nih.gov/pubmed/18349177
Cited in this article [1]
[18]
Kratzer S, Irl H, Mattusch C, et al. Tranexamic acid impairs γ-aminobutyric acid receptor type A-mediated synaptic transmission in the murine amygdala: a potential mechanism for drug-induced seizures?[J]. Anesthesiology, 2014, 120(3): 639-649. DOI: 10.1097/ALN.0000000000000103 .
https://www.ncbi.nlm.nih.gov/pubmed/24335749
Cited in this article [1]
[19]
Lecker I, Wang DS, Romaschin AD, et al. Tranexamic acid concentrations associated with human seizures inhibit glycine receptors[J]. J Clin Invest, 2012, 122(12): 4654-4666. PMCID: PMC3533541. DOI: 10.1172/JCI63375 .
https://www.ncbi.nlm.nih.gov/pubmed/23187124
Cited in this article [1]
[20]
Faraoni D, Rahe C, Cybulski KA. Use of antifibrinolytics in pediatric cardiac surgery: Where are we now?[J]. Paediatr Anaesth, 2019, 29(5): 435-440. DOI: 10.1111/pan.13533 .
https://www.ncbi.nlm.nih.gov/pubmed/30365221
Cited in this article [2]
[21]
Shin'oka T, Shum-Tim D, Jonas RA, et al. Higher hematocrit improves cerebral outcome after deep hypothermic circulatory arrest[J]. J Thorac Cardiovasc Surg, 1996, 112(6): 1610-1620; discussion 1620-1621. DOI: 10.1016/S0022-5223(96)70020-X .
https://www.ncbi.nlm.nih.gov/pubmed/8975853
Cited in this article [1]
[22]
Jonas RA, Wypij D, Roth SJ, et al. The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of a randomized trial in infants[J]. J Thorac Cardiovasc Surg, 2003, 126(6): 1765-1774. DOI: 10.1016/j.jtcvs.2003.04.003 .
https://www.ncbi.nlm.nih.gov/pubmed/14688685
Cited in this article [1]
[23]
Newburger JW, Jonas RA, Soul J, et al. Randomized trial of hematocrit 25% versus 35% during hypothermic cardiopulmonary bypass in infant heart surgery[J]. J Thorac Cardiovasc Surg, 2008, 135(2): 347-354.e4. DOI: 10.1016/j.jtcvs.2007.01.051 .
https://www.ncbi.nlm.nih.gov/pubmed/18242267
Cited in this article [1]
[24]
Wypij D, Jonas RA, Bellinger DC, et al. The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: results from the combined Boston hematocrit trials[J]. J Thorac Cardiovasc Surg, 2008, 135(2): 355-360. DOI: 10.1016/j.jtcvs.2007.03.067 .
https://www.ncbi.nlm.nih.gov/pubmed/18242268
Cited in this article [1]
[25]
Redlin M, Huebler M, Boettcher W, et al. Minimizing intraoperative hemodilution by use of a very low priming volume cardiopulmonary bypass in neonates with transposition of the great arteries[J]. J Thorac Cardiovasc Surg, 2011, 142(4): 875-881. DOI: 10.1016/j.jtcvs.2011.01.068 .
https://www.ncbi.nlm.nih.gov/pubmed/21570096
Cited in this article [1]
[26]
Lee JW, Yoo YC, Park HK, et al. Fresh frozen plasma in pump priming for congenital heart surgery: evaluation of effects on postoperative coagulation profiles using a fibrinogen assay and rotational thromboelastometry[J]. Yonsei Med J, 2013, 54(3): 752-762. PMCID: PMC3635629. DOI: 10.3349/ymj.2013.54.3.752 .
https://www.ncbi.nlm.nih.gov/pubmed/23549826
Cited in this article [1]
[27]
Faraoni D, Van der Linden P. Factors affecting postoperative blood loss in children undergoing cardiac surgery[J]. J Cardiothorac Surg, 2014, 9: 32. PMCID: PMC3924411. DOI: 10.1186/1749-8090-9-32 .
https://www.ncbi.nlm.nih.gov/pubmed/24512988
Cited in this article [1]
[28]
Desborough M, Sandu R, Brunskill SJ, et al. Fresh frozen plasma for cardiovascular surgery[J]. Cochrane Database Syst Rev, 2015, 2015(7): CD007614. PMCID: PMC8406941. DOI: 10.1002/14651858.CD007614.pub2 .
https://www.ncbi.nlm.nih.gov/pubmed/26171897
Cited in this article [1]
[29]
Riegger LQ, Voepel-Lewis T, Kulik TJ, et al. Albumin versus crystalloid prime solution for cardiopulmonary bypass in young children[J]. Crit Care Med, 2002, 30(12): 2649-2654. DOI: 10.1097/00003246-200212000-00007 .
https://www.ncbi.nlm.nih.gov/pubmed/12483054
Cited in this article [1]
[30]
Hanart C, Khalife M, De Villé A, et al. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4[J]. Crit Care Med, 2009, 37(2): 696-701. DOI: 10.1097/CCM.0b013e3181958c81 .
https://www.ncbi.nlm.nih.gov/pubmed/19114887
Cited in this article [1]
[31]
Van der Linden P, De Villé A, Hofer A, et al. Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients[J]. Anesthesiology, 2013, 119(6): 1296-1309. DOI: 10.1097/ALN.0b013e3182a6b387 .
https://www.ncbi.nlm.nih.gov/pubmed/23934169
[32]
Van der Linden P, Dumoulin M, Van Lerberghe C, et al. Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis[J]. Crit Care, 2015, 19(1): 87. PMCID: PMC4376346. DOI: 10.1186/s13054-015-0830-z .
https://www.ncbi.nlm.nih.gov/pubmed/25886765
Cited in this article [1]
[33]
Williams GD, Ramamoorthy C, Chu L, et al. Modified and conventional ultrafiltration during pediatric cardiac surgery: clinical outcomes compared[J]. J Thorac Cardiovasc Surg, 2006, 132(6): 1291-1298. DOI: 10.1016/j.jtcvs.2006.05.059 .
https://www.ncbi.nlm.nih.gov/pubmed/17140945
Cited in this article [1]
[34]
Kuratani N, Bunsangjaroen P, Srimueang T, et al. Modified versus conventional ultrafiltration in pediatric cardiac surgery: a meta-analysis of randomized controlled trials comparing clinical outcome parameters[J]. J Thorac Cardiovasc Surg, 2011, 142(4): 861-867. DOI: 10.1016/j.jtcvs.2011.04.001 .
https://www.ncbi.nlm.nih.gov/pubmed/21549396
Cited in this article [1]
[35]
Golab HD, Takkenberg JJ, van Gerner-Weelink GL, et al. Effects of cardiopulmonary bypass circuit reduction and residual volume salvage on allogeneic transfusion requirements in infants undergoing cardiac surgery[J]. Interact Cardiovasc Thorac Surg, 2007, 6(3): 335-339. DOI: 10.1510/icvts.2006.141226 .
https://www.ncbi.nlm.nih.gov/pubmed/17669859
Cited in this article [1]
[36]
Cholette JM, Powers KS, Alfieris GM, et al. Transfusion of cell saver salvaged blood in neonates and infants undergoing open heart surgery significantly reduces RBC and coagulant product transfusions and donor exposures: results of a prospective, randomized, clinical trial[J]. Pediatr Crit Care Med, 2013, 14(2): 137-147. PMCID: PMC3671922. DOI: 10.1097/PCC.0b013e31826e741c .
https://www.ncbi.nlm.nih.gov/pubmed/23287903
Cited in this article [1]
[37]
Guzzetta NA, Miller BE, Todd K, et al. An evaluation of the effects of a standard heparin dose on thrombin inhibition during cardiopulmonary bypass in neonates[J]. Anesth Analg, 2005, 100(5): 1276-1282. DOI: 10.1213/01.ANE.0000149590.59294.3A .
https://www.ncbi.nlm.nih.gov/pubmed/15845669
Cited in this article [1]
[38]
Gruenwald CE, Manlhiot C, Chan AK, et al. Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass[J]. J Am Coll Cardiol, 2010, 56(22): 1794-1802. DOI: 10.1016/j.jacc.2010.06.046 .
https://www.ncbi.nlm.nih.gov/pubmed/21087706
Cited in this article [1]
[39]
Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016[J]. Eur J Anaesthesiol, 2017, 34(6): 332-395. DOI: 10.1097/EJA.0000000000000630 .
https://www.ncbi.nlm.nih.gov/pubmed/28459785
Cited in this article [1]
[40]
Perez-Ferrer A, Vicente-Sanchez J, Carceles-Baron MD, et al. Early thromboelastometry variables predict maximum clot firmness in children undergoing cardiac and non-cardiac surgery[J]. Br J Anaesth, 2015, 115(6): 896-902. DOI: 10.1093/bja/aev369 .
https://www.ncbi.nlm.nih.gov/pubmed/26582850
Cited in this article [1]
[41]
Pekelharing J, Furck A, Banya W, et al. Comparison between thromboelastography and conventional coagulation tests after cardiopulmonary bypass surgery in the paediatric intensive care unit[J]. Int J Lab Hematol, 2014, 36(4): 465-471. DOI: 10.1111/ijlh.12171 .
https://www.ncbi.nlm.nih.gov/pubmed/24325756
Cited in this article [1]
[42]
Willems A, Harrington K, Lacroix J, et al. Comparison of two red-cell transfusion strategies after pediatric cardiac surgery: a subgroup analysis[J]. Crit Care Med, 2010, 38(2): 649-656. DOI: 10.1097/CCM.0b013e3181bc816c .
https://www.ncbi.nlm.nih.gov/pubmed/19789443
Cited in this article [1]
[43]
de Gast-Bakker DH, de Wilde RB, Hazekamp MG, et al. Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial[J]. Intensive Care Med, 2013, 39(11): 2011-2019. DOI: 10.1007/s00134-013-3085-7 .
https://www.ncbi.nlm.nih.gov/pubmed/23995984
Cited in this article [1]
[44]
Cholette JM, Rubenstein JS, Alfieris GM, et al. Children with single-ventricle physiology do not benefit from higher hemoglobin levels post cavopulmonary connection: results of a prospective, randomized, controlled trial of a restrictive versus liberal red-cell transfusion strategy[J]. Pediatr Crit Care Med, 2011, 12(1): 39-45. DOI: 10.1097/PCC.0b013e3181e329db .
https://www.ncbi.nlm.nih.gov/pubmed/20495502
Cited in this article [1]
[45]
Cholette JM, Swartz MF, Rubenstein J, et al. Outcomes using a conservative versus liberal red blood cell transfusion strategy in infants requiring cardiac operation[J]. Ann Thorac Surg, 2017, 103(1): 206-214. DOI: 10.1016/j.athoracsur.2016.05.049 .
https://www.ncbi.nlm.nih.gov/pubmed/27496630
Cited in this article [1]
[46]
Task Force on Patient Blood Management for Adult Cardiac Surgery of the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Cardiothoracic Anaesthesiology (EACTA), Boer C, Meesters MI, et al. 2017 EACTS/EACTA guidelines on patient blood management for adult cardiac surgery[J]. J Cardiothorac Vasc Anesth, 2018, 32(1): 88-120. DOI: 10.1053/j.jvca.2017.06.026 .
https://www.ncbi.nlm.nih.gov/pubmed/29029990
Cited in this article [1]
[47]
Galas FR, de Almeida JP, Fukushima JT, et al. Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial[J]. J Thorac Cardiovasc Surg, 2014, 148(4): 1647-1655. DOI: 10.1016/j.jtcvs.2014.04.029 .
https://www.ncbi.nlm.nih.gov/pubmed/24951020
Cited in this article [1]

Footnotes

所有作者均声明无利益冲突。

PDF(600 KB)
HTML

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉